MFG
HQL

Merit Financial Group’s abrdn Life Sciences Investors HQL Stock Holding History

Merit Financial Group’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262K Buy
13,076
+423
+3% +$7.47K ﹤0.01% 1907
2026
Q1 		$206K Buy
12,653
+1,403
+12% +$23.4K ﹤0.01% 1908
2025
Q4 		$189K Buy
11,250
+453
+4% +$7.61K ﹤0.01% 1836
2025
Q3 		$167K Buy
10,797
+582
+6% +$7.97K ﹤0.01% 1700
2025
Q2 		$131K Buy
+10,215
New +$126K ﹤0.01% 1612

Other funds holding HQL

1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
PFO
PMG Family Office Plano, Texas $109M AUM 15.87% 1-Year Est. Return
DI
Decision Investments San Diego, California $110M AUM
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
SFS
Shaker Financial Services Arlington, Virginia $319M AUM 3.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

Merit Financial Group's HQL Position: Q2 2026 in Review

Merit Financial Group increased its abrdn Life Sciences Investors (HQL) stake by 3.3% in Q2 2026, buying an estimated $7.47K and bringing the position to 13,076 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #1907.

Merit Financial Group first reported a position in HQL in Q2 2025 and has held it in 5 quarters since. 12 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • Merit Financial Group held 13,076 shares of abrdn Life Sciences Investors worth $262K as of Q2 2026.
  • Merit Financial Group bought 423 abrdn Life Sciences Investors shares in Q2 2026, an estimated $7.47K.
  • abrdn Life Sciences Investors made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #1907 holding.
  • Merit Financial Group first reported a position in abrdn Life Sciences Investors in Q2 2025 and has held it in 5 quarters since.
  • 12 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.